Abstract
Objective: There are few reports regarding the treatment of HTLV-I associated arthropathy (HAAP). This is a case study describing the treatment of a patient diagnosed with HAAP. We also analyzed the effects of various agents on cultured synovial tissue explants from the patient. Methods: Arthroscopic synovectomy of the left knee was performed. We investigated the effects of pirarubicin (THP), bestatin, betamethasone, and hyaluronic acid (HA) in synovial tissue culture to evaluate the efficacy of these medications. Results: Swelling and pain of the left knee was transiently diminished after synovectomy. However, bilateral swelling of the knees and C reactive protein (CRP) concentrations were increased. In the explant culture experiments, CD8+ cells decreased with the addition of bestatin, betamethasone, and HA. The structure of synovial cells was preserved by the addition of HA. However, the addition of THP induced fibrosis of synovial tissues, increased cells without nuclei, and diminished fascin-expressing cells. Conclusion: THP inhibited, but HA preserved the structure of hypertrophic synovial cells. Scopic synovectomy effectively improved joint effusion and pain; however, the effect was transient, and additional treatment with predonisolone was required. Therefore, it is important to develop a more effective treatment for HAAP.
This is a preview of subscription content, log in via an institution to check access.
References
Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031–2035
Osame MK, Usuku S, Izumo N, Ijichi H, Amitani A, Igata M, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1(8488):1031–1032
Hirose S, Uemura Y, Fujishita M, Kitagawa T, Yamashita M, Imamura J, Ohtsuki Y, Taguchi H, Miyoshi I (1986) Isolation of HTLV-I from cerebrospinal fluid of a patient with myelopathy. Lancet 2(8503):397–398
Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotypic virus-type I in patients with tropical spastic paraparesis. Lancet 2(8452):407–410
Taniguchi A, Takenaka Y, Noda Y, Ueno Y, Shichikawa K, Sato K, Miyasaka N, Nishioka K (1988) Adult T cell leukemia presenting with proliferative synovitis. Arthritis Rheum 31:1076–1077
Haynes BF, Miller SE, Palker TJ, Moore JO, Dunn PH, Bolognesi DP, Metzgar RS (1983) Identification of human T cell leukemia virus in a Japanease patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci USA 80:2054–2058
Nishioka K, Maruyama I, Sato K. Kitajima I, Nakajima Y, Osame M (1989) Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1(8635):441
Aoyagi T, Maeda K, Furuichi I. Eguchi K, Sakai M, Nagataki S, Iwasaki K (1994) Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha. Ann Rheum Dis 53:80–81
Arend WP, Dayer JM (1990) Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305–315
Sato K, Maruyama I, Maruyama Y, Kitajima I, Nakajima Y, Higaki M, Yamamoto K, Miyasaka N, Osame M, Nishioka K (1991) Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. Arthritis Rheum 34:714–721
Nishiaka K, Sumida T, Hasunuma T (1996) Human T lymphotropic virus type I in arthropathy and autoimmune disorders. Arthritis Rheum 39:1410–1418
Sagawa K, Mochizuki M, Masuoka K, Katagiri K, Katayama T, Maeda T, Tanimoto A, Sugita S, Watanabe T, Itoh K (1995) Immuno-pathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis: detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest 95:852–858
Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y (1992) Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51:769–776
Sakai M, Eguchi K, Terada K, Nakashima M, Yamashita I, Ida H, Kawabe Y, Aoyagi T, Takino H, Nakamura T, Nagataki S (1993) Infection of human synovial cells by human T lymphotropic virus type I. J Clin Invest 92:1957–1966
Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H, Uchino H (1985) Interleukin-2-receptor (Tac antigen) expressed on adult T-cell leukemia cells. J Clin Invest 76:446–453
Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M (1986) Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO (Eur Mol Biol Organ) J 5:2883–2888
Villinger PM, Cronin MT, Amenomori T, Wachsman W, Lotz M (1991). IL-6 production by human T lymphocytes expression in HTLV-I induced but not in normal T cells. J Immunol 146:550–559
Fujisawa K, Asahara H, Okamoto K, Aono H, Hasunuma T, Kobata T, Iwakura Y, Yonehara S, Sumida T, Nishioka K (1996) Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-I tax transgenic mice. J Clin Invest 98:271–278
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, T., Takemoto, S., Kiyasu, K. et al. Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis. Rheumatol Int 26, 74–79 (2005). https://doi.org/10.1007/s00296-005-0604-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-005-0604-z